Press Releases

Date	Title	Company
18-Aug-2021	Cidara Therapeutics and Mundipharma Announce Completion of Enrollment in the Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis	Cidara Therapeutics
18-Aug-2021	Stream Sensing offers in-line, real-time rheology measurement in processing industry first	Stream Sensing
18-Aug-2021	Birmingham researchers confirm speed, simplicity and sensitivity for new COVID-19 test	University of Birmingham
18-Aug-2021	Aptar Pharma Granted Exclusive License Option by Pharmaxis to Develop and Promote High Payload Dry Powder Inhaler	Aptar Pharma
18-Aug-2021	Oxurion NV - Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science, the American Academy of Ophthalmology Journal	Oxurion NV
18-Aug-2021	MITRE Proposes 10-Point Plan to Sustain a Biopharma Industrial Base and Enhance Our Nation’s Safety and Security	Businesswire
18-Aug-2021	Tiziana Announces Publication of a Peer Reviewed Article on Data from the Clinical Trial with Intranasally Administered Foralumab, Its Proprietary Fully Human Anti-CD3 Monoclonal Antibody, in Mild to Moderate COVID-19 Patients in Brazil	Tiziana Life Sciences plc
18-Aug-2021	PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments	PureTech
18-Aug-2021	Peptilogics and Cerebras Systems Partner on AI Solutions to Advance the Future of Peptide Therapeutics	Businesswire
18-Aug-2021	Medidata Announces Significant Enhancement to myMedidata Suite of Decentralized Clinical Trials (DCTs) Capabilities with Introduction of Video eConsent	Medidata
18-Aug-2021	Orion Corporation and Alligator Bioscience announce immuno-oncology research collaboration and license agreement	Orion Corporation
18-Aug-2021	ExeVir announces first subjects dosed in Phase I clinical study of potent COVID-19 neutralizing antibody	ExeVir
18-Aug-2021	Real-world data shows one shot Sputnik Light vaccine (the first component of the Sputnik V vaccine) has high safety and 93.5% efficacy against COVID during vaccination in Paraguay	Russian Direct Investment Fund
18-Aug-2021	lululemon Partners with Leading Sustainable Materials Innovator Genomatica to Bring Bio-Nylon to Products	Businesswire
18-Aug-2021	Global Wearable Medical Devices Industry (2020 to 2027) - Key Market Trends and Drivers - ResearchAndMarkets.com	Businesswire
18-Aug-2021	Oncology Devices Global Markets Report 2021: Focus on Brachytherapy, Endoscopic, Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radiation Therapy - ResearchAndMarkets.com	Businesswire
18-Aug-2021	FDA Grants Breakthrough Device Designation to Impella ECP, the World’s Smallest Heart Pump	Businesswire
18-Aug-2021	IASO Biotherapeutics Publishes Preclinical Results of Its CD5-Targeting CAR-T in American Society of Gene & Cell Therapy’s Journal, Molecular Therapy	Businesswire
18-Aug-2021	MSP Recovery Files Whistleblower Lawsuit Against 315 Auto Insurers	Businesswire
18-Aug-2021	Urovant Sciences to Present New Ambulatory Blood Pressure Data in Patients Dosed With GEMTESA® (vibegron) 75 mg for Overactive Bladder at the 2021 Annual Meeting of the American Urological Association	Businesswire